Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca’s Imfinzi receives FDA accelerated approval for previously treated patients with advance

cphi-onlineMay 05, 2017

Tag: Bladder cancer , AstraZeneca

PharmaSources Customer Service